Engineered Lactobacillus paracasei Producing Palmitoylethanolamide (PEA) Prevents Colitis in Mice

/in , /da

Autore: Giuseppe Esposito, Marcella Pesce , Luisa Seguella, Jie Lu , Chiara Corpetti, Alessandro Del Re, Fatima Domenica Elisa De Palma, Giovanni Esposito, Walter Sanseverino and Giovanni Sarnelli

Engineered Lactobacillus paracasei Producing Palmitoylethanolamide (PEA) Prevents Colitis in Mice

Potrebbero interessarti
Altered microbiome composition in individuals with fibromyalgia – PAIN
The efficacy of an association of palmitoylethanolamide and alpha-lipoic acid in patients with chronic prostatitis/chronic pelvic pain syndrome: A randomized clinical trial
HIV-1 Tat-induced diarrhea is improved by the PPARalpha agonist, palmitoylethanolamide, by suppressing the activation of enteric glia
New Targets in Pain, Non-Neuronal Cells, and the Role of Palmitoylethanolamide
Sarcopenia as potential biological substrate of long COVID-19 syndrome: prevalence, clinical features, and risk factors
Flora intestinale, antibiotici, probiotici, nutrigenomici
Prebiotic feeding elevates central brain derived neurotrophic factor, N-methyl-D-aspartate receptor subunits and D-serine
Lactoferrin as Protective Natural Barrier of Respiratory and Intestinal Mucosa against Coronavirus Infection and Inflammation